AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tagg MV 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Events Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Tagg MV 1mg/500mg/0.3mg Tablet

DiaBeta-Trio (1mg/500mg/0.3mg) tablets are classified as antidiabetic agents, a combination medication for adult-onset type 2 diabetes. This formulation aids in blood glucose regulation. DiaBeta-Trio should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Tagg MV 1mg/500mg/0.3mg Tablet

Managing Type 2 diabetes

Major Benefits of Tagg MV 1mg/500mg/0.3mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Tagg MV 1mg/500mg/0.3mg Tablet should be swallowed whole; do not crush, chew, or break it. Administer on an empty stomach.

Common Side effects of Tagg MV 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Tagg MV 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Tagg MV 1mg/500mg/0.3mg tablets on an empty stomach.

How Tagg MV 1mg/500mg/0.3mg Tablet works:

Each Tagg MV tablet (1mg/500mg/0.3mg) contains a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Tagg MV 1mg/500mg/0.3mg Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tagg MV 1mg/500mg/0.3mg Tablet during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Tagg MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Tagg MV 1mg/500mg/0.3mg tablets is likely inadvisable for individuals with kidney impairment and should be forgone. Medical advice is recommended. Furthermore, the use of Tagg MV 1mg/500mg/0.3mg tablets is discouraged in cases of severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Tagg MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Individuals with mild to moderate liver disease should begin with a low dose; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Tagg MV 1mg/500mg/0.3mg Tablet :

Should you forget to take your Tagg MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tagg MV 1mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Tagg MV 1mg/500mg/0.3mg Tablet

Tagg MV 1mg/500mg/0.3mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Tagg MV 1mg/500mg/0.3mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, rash, and respiratory infections.
Tagg MV 1mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any component, those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Tagg MV 1mg/500mg/0.3mg Tablet is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Tagg MV 1mg/500mg/0.3mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Tagg MV 1mg/500mg/0.3mg T...
89
MRP 109
18% off